Keurig Dr Pepper beats expectations despite Q4 impairment

Keurig Dr Pepper has booked Q4 results that beat analyst estimates despite the US group recording a $718m impairment for the period.Keurig Dr Pepper has booked Q4 results that beat analyst estimates despite the US group recording a $718m impairment for the period. Read More

Related posts:

Keurig Dr Pepper unveils new flavors across beverage portfolio Keurig Dr Pepper to close Virginia K-Cup production site Keurig Dr Pepper creates new role to lead energy business Keurig Dr Pepper buys US distributor Kalil Bottling Keurig pushes back Windsor plant shutdown to 2025 Sweet snacks impairments push JM Smucker into red